Linde plc, the global leader in industrial gases, is well-positioned for growth due to increasing demand from AI, semiconductor manufacturing, and clean energy sectors like hydrogen production. The company's stable business model, characterized by long-term supply contracts and high barriers to entry, provides predictable revenue and resilience against market volatility. Linde's strategic importance in key growth industries and its presence in major English-speaking markets make it an attractive investment for long-term stability and diversification, offering a blend of growth and income.

Royal Bank of Canada lowered its price target for Blackstone (NYSE:BX) from $179 to $176, while maintaining an "outperform" rating, indicating a potential 35.1% upside. Other analysts are split with eleven "Buy" and eleven "Hold" ratings, resulting in a "Moderate Buy" consensus and an average price target of $156.32. Blackstone recently surpassed quarterly earnings and revenue estimates, showing a 41.4% year-over-year revenue increase.

BMO Capital Markets has increased its price target for BlackRock (NYSE:BLK) to $1,250.00 from $1,200.00, maintaining an "outperform" rating, which suggests an 18.24% upside. This adjustment follows BlackRock's strong quarterly performance, where the asset manager exceeded analyst estimates with EPS of $12.53 and revenue of $6.70 billion, marking a 27% year-over-year revenue growth. The consensus among analysts is a "Moderate Buy" with an average target price of $1,269.06, reflecting overall confidence despite some differing price target adjustments from other firms.

Royal Bank of Canada has reduced its price target for Builders FirstSource (NYSE:BLDR) from $119 to $110, while maintaining an "outperform" rating, indicating a potential upside of nearly 24%. This adjustment follows several other brokers trimming their targets, contributing to a consensus "Hold" rating and an average price target of $118.87 for the stock. The company recently missed quarterly earnings estimates, with EPS of $1.12 against an expected $1.30 and a 12.1% year-over-year revenue decline, though a director did purchase a significant amount of shares.

Deutsche Bank Aktiengesellschaft has reduced its price target for Clorox (NYSE:CLX) from $101.00 to $100.00, maintaining a "hold" rating due to a potential 3.3% downside. This follows other analyst downgrades and a recent EPS miss where Clorox reported $1.39 against expected $1.43, with revenue declining 0.8% year-over-year. The consensus among analysts is a "Reduce" rating with an average price target of $113.87, based on mixed sentiment with only one "Buy" rating among major firms.

Wells Fargo & Company has raised its price target for Duke Energy (NYSE:DUK) to $136.00 from $135.00, maintaining an "equal weight" rating and suggesting a 6.35% upside. This comes amid mixed analyst ratings, with Duke Energy recently exceeding earnings estimates. Notably, there have been recent insider sales by the CEO and SVP.

BMO Capital Markets increased its price target for The Goldman Sachs Group (NYSE:GS) to $972 from $905, maintaining a "market perform" rating and suggesting a modest 4.3% upside from current levels. Analyst sentiment for GS is mixed, with a consensus "Hold" rating amid an average price target of $924.14. Despite a strong Q1 earnings beat, several insiders have sold shares totaling approximately $46.2 million in the last three months, though institutional investors have largely increased their positions.

AnaptysBio, Inc. has successfully spun off its biopharma operations into First Tracks Biotherapeutics, Inc., transforming itself into a royalty management entity. The company will now focus on financial collaborations for Jemperli and imsidolimab, operating virtually with minimal expenses and a strong cash position. This restructuring has led to a significant return for ANAB shareholders, with First Tracks Bio independently trading under the symbol TRAX on Nasdaq.

TD Cowen analyst Itay Michaeli has increased the price target for Autoliv, Inc. (NYSE: ALV) to $150.00 from $147.00, while maintaining their rating. This adjustment follows what the analyst describes as a "Reassuring Q1/Guide," which reportedly supports a bullish outlook for the company's stock. The full details of this analysis are available to premium subscribers.

Abacus Global Management (NYSE:ABX) is set to participate for the first time in the 2026 Milken Institute Global Conference. CEO Jay Jackson will join a panel to discuss key trends in private wealth and financial security, including aging populations, wealth transfer, and alternative investments. Other senior executives will also be present to meet with investors during the conference.